HAE News Alert Haemonetics Corp (HAE) 38.11 12/25/2014 00:25

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Haemonetics Corp (HAE) 38.11 $HAE

Haemonetics to Present at the 33rd Annual J.P. Morgan Health Care Conference
PR Newswire - Mon Dec 22, 3:00PM CST
Haemonetics Corporation (NYSE: HAE) announced today that Brian Concannon, President & CEO, will present at the 33rd Annual J.P. Morgan Health Care Conference in San Francisco on Tuesday, January 13, 2015 at 4:30 pm Pacific time / 7:30 pm Eastern time.
JPM: 62.48 (unch), HAE: 38.11 (+0.30)

Haemonetics (HAE) Upgraded From Hold to Buy
at The Street - Sat Dec 13, 7:20AM CST
Haemonetics (HAE) has been upgraded by TheStreet Ratings from Hold to Buy with a ratings score of B. 
HAE: 38.11 (+0.30)

Post Earnings Update: Haemonetics Has Climbed 6.9% Higher in Past 2 Weeks (HAE)
Comtex SmarTrend(R) - Mon Nov 17, 8:53AM CST
When Haemonetics (NYSE:HAE) reported earnings 14 days ago on November 3rd, 2014, analysts, on average, expected the company to report earnings of $0.45 on sales of $230.0 million. The company actually reported EPS of $0.47 on sales of $227.6 million, beating EPS estimates by $0.02 and missing revenue estimates by $2.4 million. Shares of Haemonetics have climbed from $34.74 to $37.13, representing a gain of 6.9% since the company reported earnings 14 days ago.
HAE: 38.11 (+0.30)

Haemonetics to Present at the Jefferies 2014 Global Healthcare Conference
PR Newswire - Tue Nov 11, 3:00PM CST
Haemonetics Corporation (NYSE: HAE) announced today that Gerry Gould, Vice President, Investor Relations, will present at the Jefferies 2014 Global Healthcare Conference in London, England on November 20, 2014 at 8:40 am GMT.
HAE: 38.11 (+0.30)

Update: Haemonetics Needs A Sales Growth Infusion Following Q3 Sales Miss And EPS Beat
Martin Vlcek - at Seeking Alpha - Wed Nov 05, 8:56AM CST

HAE: 38.11 (+0.30)

NYSE stocks posting largest percentage decreases
AP - Tue Nov 04, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on New York Stock Exchange at the close of trading:
TLM.TO: 9.10 (-0.01), HLF: 37.98 (+0.20), FRM: 7.61 (unch), TLM: 7.84 (unch), AKS: 5.76 (+0.11), CIE: 8.79 (-0.25), RCAP: 11.23 (+0.26), GDP: 4.93 (-0.22), LRE: 7.00 (-0.20), HAE: 38.11 (+0.30), S: 4.19 (-0.05), SGY: 17.83 (-0.52), BAS: 7.30 (-0.08), GVA: 38.59 (-0.07), HELI: 3.37 (-0.21), AP: 19.03 (+0.47), CRK: 7.01 (-0.20)

Haemonetics Q2 Earnings Beat Estimates but Decline Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 12:20PM CST
Haemonetics Corporation (HAE) reported adjusted earnings of 47 cents per share in the second quarter of fiscal 2015.
BSX: 13.13 (+0.07), ICUI: 83.38 (+1.63), ABAX: 58.48 (+0.22), HAE: 38.11 (+0.30)

Haemonetics' (HAE) CEO Brian Concannon on Q2 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Nov 03, 10:42AM CST

HAE: 38.11 (+0.30)

Haemonetics affirms revenue and earnings guidance after FQ2 results
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 6:54AM CST

HAE: 38.11 (+0.30)

Haemonetics beats 2Q profit forecasts
Automated Insights - Mon Nov 03, 5:18AM CST
BRAINTREE, Mass. (AP) _ Haemonetics Corp. (HAE) on Monday reported fiscal second-quarter earnings of $7.5 million.
HAE: 38.11 (+0.30)

Haemonetics beats by $0.01, misses on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 5:02AM CST

HAE: 38.11 (+0.30)

Haemonetics Reports 2nd Quarter Fiscal 2015 Revenue of $228 Million and Adjusted EPS of $0.47; Reaffirms Revenue and Earnings Guidance
PR Newswire - Mon Nov 03, 5:00AM CST
Haemonetics Corporation (NYSE: HAE) today reported second quarter fiscal 2015 revenue of $227.6 million, down 3.5%. In constant currency, revenue declined 2.6% in the quarter. The Company reported second quarter GAAP net income of $7.5 million and GAAP net income per share of $0.14. Exclusive of transformation, restructuring and deal amortization expenses detailed below, adjusted net income was $24.3 million and adjusted earnings per share were $0.47, both down 29%.[1]
HAE: 38.11 (+0.30)

Notable earnings before Monday’s open
Seeking Alpha - at Seeking Alpha - Sun Nov 02, 4:30PM CST

ACW: 4.30 (+0.01), SYY: 40.59 (-0.11), L: 42.37 (-0.20), EEP: 38.84 (+0.11), SNH: 22.07 (+0.04), INN: 12.47 (+0.03), ITG: 20.72 (-0.40), NSP: 34.53 (+0.01), S: 4.19 (-0.05), ALE: 55.81 (+0.61), GVA: 38.59 (-0.07), MCY: 55.84 (+0.68), ARNA: 3.57 (-0.01), CHD: 80.16 (-0.37), ARE: 89.23 (-0.23), USAK: 25.88 (+0.46), BWP: 17.53 (-0.14), KRG: 28.69 (-0.03), CYOU: 25.85 (+0.42), MNKD: 5.68 (+0.18), HNT: 53.73 (+0.02), AMH: 17.34 (-0.07), ARCB: 46.21 (-0.09), ANIP: 55.24 (+1.79), AMG: 213.80 (-0.27), HAE: 38.11 (+0.30), SOHU: 51.80 (-0.22), CNA: 38.93 (-0.06)

Haemonetics reports November 3
Seeking Alpha - at Seeking Alpha - Sat Nov 01, 4:46PM CDT

HAE: 38.11 (+0.30)

Is Haemonetics (HAE) Poised to Beat on Q2 Earnings? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 5:15PM CDT
Haemonetics (HAE) has delivered positive earnings surprises in three of the past four quarters with an average beat of 1.9%
HAE: 38.11 (+0.30), HTWR: 72.62 (+0.02), HOLX: 26.89 (+0.10), HSP: 62.60 (-0.07)

3PEA International and Haemonetics Partner to Integrate PaySign Connect with Haemonetics' Donor Management System
Business Wire - Tue Oct 21, 7:49AM CDT
3PEA International, Inc. (OTCBB:TPNL)(OTCQB:TPNL), a vertically integrated provider of innovative prepaid card programs and processing services for corporate, consumer and government applications, today announced that 3PEA and Haemonetics Corporation (NYSE:HAE) have entered into an agreement whereby 3PEA International will integrate its PaySign(R) Connect prepaid debit card solution with Haemonetics' Donor Management System ("DMS" . The integration will allow users of the Haemonetics DMS to use the PaySign Connect payment solution for the plasma industry. This partnership will bring together the best of both worlds, the industry leading Haemonetics Donor Management System and 3PEA's PaySign(R) Connect, an intuitive, easy-to-use, fully tokenized payment system tailored to the unique requirements of the plasma collection industry.
HAE: 38.11 (+0.30)

Haemonetics Sets Date for Second Quarter Fiscal Year 2015 Earnings Release: November 3, 2014
PR Newswire - Mon Oct 06, 3:00PM CDT
Haemonetics Corporation (NYSE:HAE) will announce its earnings for the second quarter of its fiscal year 2015 on November 3, 2014 in a pre-market press release. The Company will host a webcast to discuss and answer questions about the press release at 8:00 am eastern time on November 3, 2014.
HAE: 38.11 (+0.30)

Perrigo Sells Some Assets to Imago Pharmaceuticals - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 03, 3:45PM CDT
Perrigo (PRGO) has out licensed some of its early-stage assets.
BIIB: 340.89 (+5.13), PRGO: 166.11 (+1.96), ABAX: 58.48 (+0.22), HAE: 38.11 (+0.30)

Walgreens Earnings in Line, Alliance Boots Shows Synergy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 30, 9:45AM CDT
Walgreen Co. (WAG) reported adjusted net earnings of 74 cents per share in the fourth quarter of fiscal 2014.
ABAX: 58.48 (+0.22), HAE: 38.11 (+0.30), CVS: 97.89 (+0.02), WAG: 76.67 (+0.16)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sidus Gains Argotec Order, but Investors Need the Math

Updated Category News Views 161

A Real Customer Signal, Minus the Revenue Figure An updated image is the least interesting detail in this release. Sidus Space has landed a purchase order from Argotec Group to manufacture cable assemblies for the HAWK satellite platform, with delivery expected in the first quarter of 2027. That is a legitimate operational win for NASDAQ:SIDU. It brings in a new...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 78

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
Cottage Grove Tests Holiday Demand Across Lake Norman

Updated Category News Views 139

Flour and foot traffic make a pretty honest little scoreboard. Cottage Grove Bakery is putting itself in front of Lake Norman shoppers twice on Saturday, November 21, while also taking Thanksgiving orders and laying groundwork for 2027 workplace and school visits. This is not a public-company earnings story, and nobody should pretend a tray of scones is a quarterly...

Continue Reading
California Initiative Puts Missed Diagnoses in Focus

Updated Category News Views 161

When Reassurance Turns Into a Risk A clean scan can become a dangerous lullaby when symptoms refuse to leave. That is the hard, unsettling territory behind Hodes Milman’s new Missed Diagnosis Project: California, launched November 20, 2026. The statewide effort focuses on breast cancer diagnostic failures: scans read as benign when more scrutiny was warranted, referrals...

Continue Reading
Highmark’s 2026 Rebound Has a Few Asterisks Attached

Updated Category News Views 74

The Headline Needs a Pencil, Not a Highlighter A $1.9 billion net-income figure can look downright thunderous until you separate the cash-generating engine from the accounting cargo strapped to it. Highmark Health reported $26.5 billion in revenue and $741 million in operating income for the nine months ended Sept. 30, 2026. Those are materially better numbers than the...

Continue Reading
Domino's Probe Puts Franchise Disclosure Under Lens

Updated Category News Views 139

A franchisee's shuttered stores can turn cheerful unit-growth talk into a nasty accounting of credibility, and that is the uncomfortable territory Domino's now occupies. Kahn Swick & Foti has opened an investigation into whether Domino's officers and directors breached fiduciary duties or violated state or federal law. That is not a finding of misconduct. It is a legal...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 121

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
QuidelOrtho Faces Fresh Scrutiny Over Savanna Claims

Updated Category News Views 157

A diagnostic launch can turn into a corporate migraine with frightening speed, and QuidelOrtho is staring at exactly that sort of mess. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether QuidelOrtho officers or directors breached fiduciary duties or otherwise violated state or federal law. This is not a finding of wrongdoing. It is an...

Continue Reading
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 92

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 154

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Market Sentiment Around Primerica's Stock

Updated Category News Views 89

Market Sentiment and Primerica's Stock Insights Primerica (NYSE: PRI) has seen a notable change in its short interest recently. The short percent of float has decreased by 11.7% since the last reporting period, indicating a shift in trader sentiment. Currently, there are approximately 219 thousand shares sold short, which accounts for about 0.83% of all regular shares...

Continue Reading
Applied Digital Corporation Secures Major $5 Billion Contract

Updated Category News Views 189

Applied Digital Corporation Celebrates New Milestone Applied Digital Corporation (NASDAQ: APLD) has secured a transformative contract that shines a spotlight on its ambitious Polaris Forge 2 Campus project. The deal, valued at a staggering $5 billion, involves a 15-year lease agreement with a U.S.-based investment-grade hyperscaler. This significant venture is poised to...

Continue Reading
Carnival Cruise Lines on Track for Major Gains in 2025

Updated Category News Views 611

Carnival Cruise Lines Poised for Growth in 2025 Carnival Cruise Lines (NYSE: CCL) has seen a remarkable increase in its share price, rising by approximately 50% as we head into 2024. This upward trend reflects a resilient business model and robust operational efficiencies. Expectations for fiscal 2025 are bolstered by the ongoing normalization of the cruise industry...

Continue Reading
CAS Space Chairman Aims to Build Rockets Like Cars

Updated Category News Views 24

Rocket Science on the Fast Lane Welcome to a new chapter in the space race, where Yang Yiqiang of CAS Space is steering the vision. When you think of rockets, you might imagine a symphony of math and metal, far removed from the everyday grind of car production. But Yang, itching to shuffle that status quo, wants rockets rolling off assembly lines like cars—an idea...

Continue Reading
Vodafone's Strategic Cash Tender Offers Announced for 2025-2028 Bonds

Updated Category News Views 507

Vodafone Group Initiates Cash Tender Offers for Outstanding Notes Vodafone Group Plc, a prominent telecommunications company, has announced its plans to launch cash tender offers for its outstanding U.S. dollar notes due in 2025 and 2028. This strategic move is aimed at managing its debt efficiently, particularly focusing on reducing near-term maturities that could impact...

Continue Reading